Menu Search
Equities

BIOAGE Labs Inc

Y7G:STU

BIOAGE Labs Inc

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at BIOAGE Labs Inc fell by 2.69m. Cash Flow from Financing totalled 34.94m or -- of revenues. In addition the company used 37.36m for operations while cash used for investing totalled 266.00k.
Cash flow per share-1.81
Price/Cash flow per share--
Book value per share4.26
Tangible book value per share4.26
More ▼

Balance sheet in USDView more

BIOAGE Labs Inc appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, this company's debt load is greater than its assets while day-to-day operations are losing money. BIOAGE Labs Inc has considerable financial risk.
Current ratio12.61
Quick ratio--
Total debt/total equity0.078
Total debt/total capital0.0724
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.